Westchester Capital Management (New York)’s Translational Development Acquisition Corp TDAC Stock Holding History

Westchester Capital Management (New York)’s Portfolio TDAC Stock Details TDAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Sell	124,328 -124,524	-50%	-$1.33M	0.07%	192
2026 Q1	$2.63M	Hold	248,852	–	–	0.12%	135
2025 Q4	$2.61M	Hold	248,852	–	–	0.11%	128
2025 Q3	$2.57M	Buy	+248,852	New	+$2.57M	0.12%	129

Other funds holding TDAC

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Westchester Capital Management (New York)'s TDAC Position: Q2 2026 in Review

Westchester Capital Management (New York) reduced its Translational Development Acquisition Corp (TDAC) stake by 50% in Q2 2026, selling an estimated $1.33M and leaving 124,328 shares worth $1.33M. The position accounts for 0.07% of the portfolio, ranked #192.

Westchester Capital Management (New York) first reported a position in TDAC in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.63M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

Westchester Capital Management (New York) held 124,328 shares of Translational Development Acquisition Corp worth $1.33M as of Q2 2026.
Westchester Capital Management (New York) sold 124,524 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1.33M.
Translational Development Acquisition Corp made up 0.07% of Westchester Capital Management (New York)'s portfolio in Q2 2026, its #192 holding.
Westchester Capital Management (New York) first reported a position in Translational Development Acquisition Corp in Q3 2025 and has held it in 4 quarters since.
Westchester Capital Management (New York)'s Translational Development Acquisition Corp position peaked at $2.63M in Q1 2026.
35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.